CTX-M-15 extended-spectrum β-lactamases in Enterobacteriaceae in the intensive care unit of Tlemcen Hospital, Algeria;Détection de β-lactamases CTX-M-15 à spectre élargi chez enterobacteriaceae dans l'unité de soins intensifs de l'hôpital de Tlemcen (Algérie)

Eastern Mediterranean Health Journal

Volumn 18, Issue 4, 2012, Pages 382-386

  Ahmed, Z Baba ^a   Ayad, A ^a   Mesli, E ^a   Messai, Y ^b   Bakour, R ^b   Drissi, M ^a  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA LACTAMASE CTX M 15; BETA-LACTAMASE CTX-M-15;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CTX-M-15 GENE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE; GENE INSERTION SEQUENCE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MOLECULAR TYPING; PLASMID; ALGERIA; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIUM IDENTIFICATION; CLASSIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

ALGERIA; ANTI-INFECTIVE AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 84864754913     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2012.18.4.382     Document Type: Article

References (24)

1. Livermore DM, Woodford N. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends in Microbiology, 2006, 14:413-414.
2. Hawkey PM, Jones AM. The changing epidemiology of resistance. Journal of Antimicrobial Chemotherapy, 2009, 64(Suppl. 1):3-10.
3. Bonnet R. Growing group of extended-spectrum beta-lactamases. The CTX-M enzymes. Antimicrobial Agents and Chemotherapy, 2004, 48:1-14.
4. CA-SFM. Comité de l'Antibiogramme de la Société Française de Microbiologie (2008) (http://www.sfm-microbiologie.org, accessed 5 March 2012).
5. Jarlier V et al. Extended broad- spectrum beta-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalance and susceptibility patterns. Reviews of Infectious Diseases, 1988, 4:143-149.
6. Decré D et al. Outbreak of multiresistant Klebsiella oxytoca involving strains with extended-spectrum β-lactamase. Journal of Antimicrobial Chemotherapy, 2004, 54:881-888.
7. Messai Y et al. Prevalence and characterisation of extended- spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathologie Biologie, 2008, 56:319-325.
8. Poirel L, Decousser JW, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrobial Agents and Chemotherapy, 2003, 47:2938-2945.
9. Bakour R, Laroche Y, Cornelis G. Study of the incompatibility and replication of the 70-kb virulence plasmid of Yersinia. Plasmid, 1983, 10:279-289.
10. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. Journal of Bacteriology, 1981, 45:1365-1373.
11. Wang H et al. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrobial Agents and Chemotherapy, 2003, 47:790-793.
12. Touati A et al. First report of CTX-M-15 and CTX-M-3 betalactamases among clinical isolates of Enterobacteriaceae in Béjaia, Algeria. International Journal of Antimicrobial Agents, 2006, 27:397-402.
13. Iabadene H et al. Dissemination of ESBL and Qnr determinants in Enterobacter cloacea in Algeria. Journal of Antimicrobial Chemotherapy, 2008, 62:133-136.
14. Ramdani-Bouguessa N et al. CTX-M-3 and CTX-M-15 extendedspectrum β-lactamases in isolates of Escherichia coli from a Hospital in Algiers, Algeria. Journal of Clinical Microbiology, 2006, 44:4584-4586.
15. Quinteros M. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals. Antimicrobial Agents and Chemotherapy, 2003, 47:2864-2867.
16. Baraniak A et al. Countrywide spread of CTX-M-3 extendedspectrum β-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrobial Agents and Chemotherapy, 2002, 46:151-159.
17. Moubareck C et al. Countrywide spread of community- and hospital-acquired extended-spectrum β-lactamase (CTXM- 15)-producing Enterobacteriaceae in Lebanon. Journal of Clinical Microbiology, 2005, 43:3309-3313.
18. Kanj SS et al. Molecular characterisation of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. isolates at a tertiary-care centre in Lebanon. Clinical Microbiology and Infection, 2008, 14:501-504.
19. Gangoue-Pieboji J et al. Emergence of CTX-M-15-producing Enterobacteriaceae in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrobial Agents and Chemotherapy, 2005, 49:441-443.
20. Woodford N et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. Journal of Antimicrobial Chemotherapy, 2004, 54:735-743.
21. Lewis JS et al. First report of the emergence of CTX-M-type extended-spectrum-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrobial Agents and Chemotherapy, 2007, 51:4015-4021.
22. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. Journal of Antimicrobial Chemotherapy, 2006, 57:14-23.
23. Silva J et al. Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital. Journal of Clinical Microbiology, 2001, 39:3193-3196.
24. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Annals of Internal Medicine, 2001, 134:298-314.